Octreotide is the favorable alternative for cisplatin resistance reversal of ovarian cancer in vitro and in nude mice in vivo.
Year: 2012
Type: article
Source: PubMed
Authors: Y Shen, M L Ren, Y H Shi, Y X Zhang, Y L Cai
Institutions: Zhongda Hospital Southeast University, Southeast University
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2397081895
